Medicilon is a Preclinical Research Outsourcing (CRO) company. With our more than 10 years experience on preclinical research services, we dedicated to provide our clients with customized preclinical services program in drug metabolism, pharmacokinetics, efficacy studies, and toxicology. We provide our clients a high-quality data and rapid turnaround time to support their drug development, preclinical studies and clinical research and to help them to select the most valuable drug candidates into clinical trials stage. Our preclinical research services consist in three major parts: pharmacokinetics, disease transplantation models and drug safety evaluation. Our preclinical research services cover all of the aspects including design, in vivo studies, sample analysis, professional data analysis, IACUC review, and the preparation of application materials.
Preclinical Research Services
Quick start experiments and flexible experimental design help you to speed up your decisions and lower your research cost.
Perfect and Complete Preclinical Research Laboratories
Medicilon owns 50,000 square meters of R & D laboratories and state-of-the-art equipments. Our labs are certified by Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and comply with the GLP standard of US FDA and CFDA. Our preclinical safety evaluations also comply with the Organization for Economic Cooperation and Development in Europe (OECD) GLP requirements.
Medicilon is the first CRO to offer preclinical animal testing service for the global pharmaceutical companies in China. Some of the platform provided by Medicilon such as Drugs Safety Evaluation for Non-Human Primates Services Platform and Isotope Drug Metabolism Professional Services Platform is certified by Shanghai government. In addition, our platform is certified and identified as an important drug discovery platform by Shanghai government.